Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study
Date
2019Dewey
Economie socialeSujet
Prospective Studies; Europe; epidemiology; Treatment Outcome; ETNA-AF-Europe study; PREFER in AFJEL code
I.I1.I12; I.I1.I11Journal issue
Journal of Cardiovascular MedicineVolume
20Number
2Publication date
2019Article pages
97-104Publisher
Wolters KluwerCollections
Metadata
Show full item recordAuthor
De Caterina, Raffaele
504746 Institute of Clinical Physiology
Kelly, Peter
19761 NS Research
121353 Division of Medicine
163414 Neurovascular Clinical Science Unit, Catherine McAuley Centre
121353 Division of Medicine
163414 Neurovascular Clinical Science Unit, Catherine McAuley Centre
Monteiro, Pedro
Deharo, Jean Claude
532052 Département de Cardiologie [Hôpital de la Timone - APHM]
de Asmundis, Carlo
López-de-Sá, Esteban
Weiss, Thomas W.
Waltenberger, Johannes
Steffel, Jan
de Groot, Joris R.
Lévy, Pierre
163511 Laboratoire d'Economie de Dauphine [LEDa]
163517 Laboratoire d'Economie et de Gestion des Organisations de Santé [Legos]
163517 Laboratoire d'Economie et de Gestion des Organisations de Santé [Legos]
Bakhai, Ameet
Zierhut, Wolfgang
45340 Department of Medicine, Royal Free [DEPARTMENT OF MEDICINE, ROYAL FREE]
Laeis, Petra
531292 Daiichi Sankyo Inc.
Reimitz, Paul-Egbert
Kirchhof, Paulus